Log in to save to my catalogue

Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological sign...

Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological sign...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2545991519

Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance

About this item

Full title

Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance

Publisher

New York: Springer US

Journal title

Molecular and cellular biochemistry, 2021-11, Vol.476 (11), p.3935-3950

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Extracellular matrix (ECM) plays an important role in the structural organization of tissue and delivery of external cues to the cell. Biglycan, a class I small leucine-rich proteoglycans (SLRP), is a key component of the ECM that participates in scaffolding the collagen fibrils and mediates cell signaling. Dysregulation of biglycan expression can...

Alternative Titles

Full title

Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2545991519

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2545991519

Other Identifiers

ISSN

0300-8177,1573-4919

E-ISSN

1573-4919

DOI

10.1007/s11010-021-04216-z

How to access this item